Opioid-Naive, Hypercapnic, and Dyspneic: Starting an Opioid When the Family Fears It Will Kill Her
Ms. K is 81, admitted from home with dyspnea 8/10 and back pain 7/10 from a T12 compression fracture. She has advanced COPD (FEV1 33% predicted), is on 2 L/min nasal cannula at home, and has an eGFR of 22 mL/min. She is opioid-naive: no opioid in the last year, and she takes only tiotropium, albuterol, and lorazepam 0.5 mg at bedtime as needed. On admission: alert and oriented, respiratory rate 26, SpO2 91% on 2 L, arterial CO2 52 mmHg, and she is anxious and exhausted. Her daughter says, 'The last nurse told me morphine would make her stop breathing. I don't want you to kill my mother.' Goals of care documented as comfort-focused.
1. Choose an agent, route, and starting dose, and justify your choice against morphine and against benzodiazepines. Show your reasoning about her organ function and her CO2.
Read the worked answer
Choose a low-dose, short-acting opioid with a clean renal profile, titrated to effect.
- Hydromorphone 0.25 mg PO every 4 hours as needed, or 0.2 mg IV every 2-4 hours if she cannot swallow reliably. Oxycodone 2.5 mg PO is a reasonable alternative.
- Why not morphine: at an eGFR of 22, morphine-6-glucuronide accumulates and produces delayed sedation and respiratory depression - exactly the outcome the daughter fears, and exactly the wrong drug to prove her wrong with. Fentanyl is also defensible (no active metabolites) but is harder to titrate in an opioid-naive older adult outside a monitored setting.
- Why start low rather than at standard adult doses: opioid-naive, age 81, low body weight, and hypercapnia all reduce the therapeutic window. The correct starting dose is one you can titrate upward safely; a dose that overshoots destroys trust and makes the family's fear look confirmed.
- Why not a benzodiazepine for the dyspnea: lorazepam does not relieve dyspnea and increases the risk of delirium, falls, and hypercapnia. Keep her bedtime dose as needed only, and do not add standing benzodiazepines.
- Opioids for dyspnea are standard palliative practice, not a deviation: low doses blunt the air-hunger sensation, reduce respiratory drive modestly, and improve the work of breathing.
- Non-pharmacologic first-line partners: a handheld fan to the face, upright positioning, pacing, and oxygen titrated to 88-92% (do not chase 100% in a CO2 retainer).
Document the rationale in the chart so the next covering clinician does not 'correct' the low dose upward reflexively.
2. Design the monitoring and rescue plan. What thresholds trigger action, what action, and how do you avoid abandoning comfort in the process?
Read the worked answer
Baseline and frequency
- Before the first dose: respiratory rate, sedation score, SpO2, and a pain/dyspnea score. Reassess 30-60 minutes after each dose and at least every 4 hours once stable.
- Sedation is the earlier and more reliable warning than respiratory rate. Track both; a patient who is increasingly somnolent with a rate of 12 is already in trouble.
Thresholds and actions
- Rate 8-10 with easy arousal: reduce the next dose by 25-50%, increase observation, and look for a reversible cause (hypercapnia, atelectasis, over-sedation from stacked lorazepam).
- Rate below 8 or unarousable: stop the opioid, stimulate, give oxygen, and titrate naloxone in small aliquots (0.04-0.1 mg IV, repeated every 2 minutes) with the goal of restoring adequate ventilation, not full reversal. Full-dose naloxone in a comfort-focused patient will precipitate pain, agitation, and air hunger and is itself cruel.
- Do not add a standing benzodiazepine to 'cover' agitation that is really under-treated dyspnea or opioid-induced myoclonus.
- Monitor for hypercapnia clinically (drowsiness, headache, flushing); repeat blood gas only if it will change management.
Avoiding abandonment of comfort
- Frame the monitoring as dose-finding, not as restriction: 'We will start small and go up until she is comfortable, watching her breathing at each step.'
- Keep a standing order for breakthrough dyspnea and pain so the next clinician does not withhold for fear of the family's reaction.
- If respiratory depression occurs, that is a signal to adjust the dose, not to switch to a 'less risky' non-opioid that does not work.
3. How do you answer the daughter's fear directly, and what do you teach her over the next 24 hours?
Read the worked answer
Acknowledge, correct the misimpression, and reframe intent.
- "You are right to ask, and I am glad you did. The dose we are starting is very small and chosen specifically because her kidneys and lungs are fragile. It is meant to make her breathing feel less like work, not to stop it."
- Explain the difference between treating a symptom and hastening death: the opioid is given in the smallest amount that relieves her air hunger and pain, and it is adjusted to her response. If a dose ever seems to be causing harm, we reduce it - that is what the monitoring is for.
- Be honest about uncertainty without frightening her: "In someone this ill, it can be hard to separate the medicine's effect from the illness itself. What I can promise is that every dose will be tied to whether she looks comfortable."
Teach her
- What comfort looks like: slower, easier breathing, unwrinkled forehead, shoulders down, able to doze.
- What to report: breathing slower than 8 per minute, difficulty waking her, new noisy breathing, restlessness that looks like air hunger.
- Why there is no ceiling on comfort but there is a ceiling on safety: doses escalate only after assessment.
- Ask about her own support - a daughter watching a parent die is a patient too; offer the palliative care team and chaplaincy by name, and make sure she knows she can stay at the bedside.
Document the conversation and the goals-of-care discussion so the whole team uses the same language.